TCW Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $64.3M | Sell |
2,669,765
-43,819
| -2% | -$1.15M | 0.43% | 71 |
|
|
2026
Q1 | $76.2M | Buy |
2,713,584
+113,319
| +4% | +$3.02M | 0.57% | 54 |
|
|
2025
Q4 | $64.7M | Buy |
+2,600,265
| New | +$65.6M | 0.46% | 61 |
|
|
2025
Q3 | – | Sell |
-85,852
| Closed | -$2.08M | – | 325 |
|
|
2025
Q2 | $2.08M | Buy |
85,852
+1,791
| +2% | +$41.8K | 0.02% | 257 |
|
|
2025
Q1 | $2.13M | Buy |
84,061
+4,523
| +6% | +$118K | 0.02% | 243 |
|
|
2024
Q4 | $2.11M | Buy |
79,538
+1,971
| +3% | +$53.5K | 0.02% | 253 |
|
|
2024
Q3 | $2.24M | Sell |
77,567
-1,829
| -2% | -$53.4K | 0.02% | 247 |
|
|
2024
Q2 | $2.22M | Buy |
79,396
+3,316
| +4% | +$91.3K | 0.02% | 252 |
|
|
2024
Q1 | $2.11M | Sell |
76,080
-129,296
| -63% | -$3.59M | 0.02% | 239 |
|
|
2023
Q4 | $5.91M | Buy |
205,376
+92,970
| +83% | +$2.81M | 0.07% | 171 |
|
|
2023
Q3 | $3.73M | Sell |
112,406
-6,208
| -5% | -$220K | 0.05% | 182 |
|
|
2023
Q2 | $4.35M | Buy |
118,614
+4,214
| +4% | +$164K | 0.05% | 177 |
|
|
2023
Q1 | $4.67M | Buy |
114,400
+59,517
| +108% | +$2.57M | 0.06% | 168 |
|
|
2022
Q4 | $2.81M | Sell |
54,883
-237
| -0.4% | -$11.4K | 0.04% | 183 |
|
|
2022
Q3 | $2.41M | Sell |
55,120
-14,190
| -20% | -$690K | 0.04% | 208 |
|
|
2022
Q2 | $3.63M | Buy |
69,310
+2,687
| +4% | +$137K | 0.05% | 196 |
|
|
2022
Q1 | $3.45M | Sell |
66,623
-13,465
| -17% | -$699K | 0.03% | 207 |
|
|
2021
Q4 | $4.73M | Sell |
80,088
-3,441
| -4% | -$170K | 0.04% | 206 |
|
|
2021
Q3 | $3.59K | Buy |
83,529
+1,066
| +1% | +$47.2K | 0.01% | 224 |
|
|
2021
Q2 | $3.23M | Sell |
82,463
-60,664
| -42% | -$2.36M | 0.03% | 231 |
|
|
2021
Q1 | $5.18M | Buy |
143,127
+11,267
| +9% | +$400K | 0.05% | 198 |
|
|
2020
Q4 | $4.85M | Sell |
131,860
-5,591
| -4% | -$205K | 0.04% | 192 |
|
|
2020
Q3 | $4.79M | Buy |
137,451
+8,341
| +6% | +$292K | 0.05% | 174 |
|
|
2020
Q2 | $4.01M | Sell |
129,110
-38,760
| -23% | -$1.32M | 0.05% | 174 |
|
|
2020
Q1 | $5.2M | Sell |
167,870
-642
| -0.4% | -$21.9K | 0.07% | 151 |
|
|
2019
Q4 | $6.26M | Buy |
168,512
+6,798
| +4% | +$242K | 0.07% | 154 |
|
|
2019
Q3 | $5.51M | Sell |
161,714
-1,230
| -0.8% | -$44.7K | 0.06% | 156 |
|
|
2019
Q2 | $6.7M | Sell |
162,944
-4,232
| -3% | -$168K | 0.07% | 146 |
|
|
2019
Q1 | $6.74M | Buy |
167,176
+1,658
| +1% | +$66.4K | 0.06% | 153 |
|
|
2018
Q4 | $6.85M | Sell |
165,518
-7,970
| -5% | -$331K | 0.07% | 145 |
|
|
2018
Q3 | $7.25M | Sell |
173,488
-4,714
| -3% | -$181K | 0.06% | 150 |
|
|
2018
Q2 | $6.13M | Buy |
178,202
+13,507
| +8% | +$462K | 0.05% | 156 |
|
|
2018
Q1 | $5.55M | Sell |
164,695
-6,547
| -4% | -$225K | 0.05% | 156 |
|
|
2017
Q4 | $5.88M | Buy |
171,242
+15,872
| +10% | +$541K | 0.05% | 156 |
|
|
2017
Q3 | $5.26M | Sell |
155,370
-598,746
| -79% | -$19.2M | 0.04% | 169 |
|
|
2017
Q2 | $24M | Sell |
754,116
-2,453,647
| -76% | -$77.4M | 0.2% | 95 |
|
|
2017
Q1 | $104M | Sell |
3,207,763
-537,195
| -14% | -$16.9M | 0.87% | 47 |
|
|
2016
Q4 | $115M | Sell |
3,744,958
-165,757
| -4% | -$5.06M | 0.87% | 47 |
|
|
2016
Q3 | $126M | Sell |
3,910,715
-1,045,803
| -21% | -$35M | 0.95% | 40 |
|
|
2016
Q2 | $166M | Sell |
4,956,518
-556,951
| -10% | -$17.8M | 1.25% | 24 |
|
|
2016
Q1 | $155M | Buy |
5,513,469
+371,336
| +7% | +$10.6M | 1.14% | 25 |
|
|
2015
Q4 | $157M | Sell |
5,142,133
-393,318
| -7% | -$12.4M | 1.13% | 28 |
|
|
2015
Q3 | $165M | Buy |
5,535,451
+264,627
| +5% | +$8.48M | 1.18% | 25 |
|
|
2015
Q2 | $168M | Sell |
5,270,824
-1,531,030
| -23% | -$49.9M | 1.08% | 26 |
|
|
2015
Q1 | $225M | Sell |
6,801,854
-1,618,043
| -19% | -$51.4M | 1.08% | 19 |
|
|
2014
Q4 | $249M | Sell |
8,419,897
-732,490
| -8% | -$21M | 1.04% | 26 |
|
|
2014
Q3 | $257M | Sell |
9,152,387
-5,914
| -0.1% | -$166K | 1.03% | 22 |
|
|
2014
Q2 | $258M | Sell |
9,158,301
-1,843,780
| -17% | -$52.6M | 1.06% | 19 |
|
|
2014
Q1 | $335M | Buy |
11,002,081
+97,685
| +0.9% | +$2.91M | 1.39% | 8 |
|
|
2013
Q4 | $317M | Buy |
10,904,396
+4,871
| +0% | +$142K | 1.34% | 8 |
|
|
2013
Q3 | $297M | Sell |
10,899,525
-395,892
| -4% | -$10.8M | 1.37% | 8 |
|
|
2013
Q2 | $300M | Buy |
+11,295,417
| New | +$312M | 1.48% | 5 |
|
Other funds holding PFE
TCW Group's PFE Position: Q2 2026 in Review
TCW Group reduced its Pfizer (PFE) stake by 1.6% in Q2 2026, selling an estimated $1.15M and leaving 2,669,765 shares worth $64.3M. The position accounts for 0.43% of the portfolio, ranked #71.
TCW Group first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $335M in Q1 2014. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- TCW Group held 2,669,765 shares of Pfizer worth $64.3M as of Q2 2026.
- TCW Group sold 43,819 Pfizer shares in Q2 2026, an estimated $1.15M.
- Pfizer made up 0.43% of TCW Group's portfolio in Q2 2026, its #71 holding.
- TCW Group first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- TCW Group's Pfizer position peaked at $335M in Q1 2014.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on TCW Group's 13F filing for Q2 2026, filed 3 Aug 2026.